Drosophila model to clarify the pathological significance of OPA1 in autosomal dominant optic atrophy

被引:0
|
作者
Nitta, Yohei [1 ]
Osaka, Jiro [1 ,2 ]
Maki, Ryuto [2 ]
Hakeda-Suzuki, Satoko [2 ,3 ]
Suzuki, Emiko [4 ,5 ]
Ueki, Satoshi [6 ]
Suzuki, Takashi [2 ]
Sugie, Atsushi [1 ]
机构
[1] Niigata Univ, Brain Res Inst, Niigata, Japan
[2] Tokyo Inst Technol, Sch Life Sci & Technol, Yokohama, Japan
[3] Yokohama Natl Univ, Res Initiat & Promot Org, Yokohama, Japan
[4] Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Hachioji, Japan
[5] Natl Inst Genet, Dept Gene Funct & Phenom, Mishima, Japan
[6] Niigata Univ, Grad Sch Med & Dent Sci, Div Ophthalmol & Visual Sci, Niigata, Japan
来源
ELIFE | 2024年 / 12卷
基金
日本学术振兴会;
关键词
dominant optic atrophy; Drosophila; OPA1; axonal degeneration; DYNAMIN-RELATED PROTEIN; SCLEROSIS-LIKE DISORDER; MITOCHONDRIAL-DNA; MUTATIONS; DISEASE; REPLICATION; FUSION; GENES; MOUSE; PATHOGENICITY;
D O I
10.7554/eLife.87880
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Autosomal dominant optic atrophy (DOA) is a progressive form of blindness caused by degeneration of retinal ganglion cells and their axons, mainly caused by mutations in the OPA1 mitochondrial dynamin like GTPase (OPA1) gene. OPA1 encodes a dynamin-like GTPase present in the mitochondrial inner membrane. When associated with OPA1 mutations, DOA can present not only ocular symptoms but also multi-organ symptoms (DOA plus). DOA plus often results from point mutations in the GTPase domain, which are assumed to have dominant-negative effects. However, the presence of mutations in the GTPase domain does not always result in DOA plus. Therefore, an experimental system to distinguish between DOA and DOA plus is needed. In this study, we found that loss-of-function mutations of the dOPA1 gene in Drosophila can imitate the pathology of optic nerve degeneration observed in DOA. We successfully rescued this degeneration by expressing the human OPA1 (hOPA1) gene, indicating that hOPA1 is functionally interchangeable with dOPA1 in the fly system. However, mutations previously identified did not ameliorate the dOPA1 deficiency phenotype. By expressing both WT and DOA plus mutant hOPA1 forms in the optic nerve of dOPA1 mutants, we observed that DOA plus mutations suppressed the rescue, facilitating the distinction between loss-of-function and dominant-negative mutations in hOPA1. This fly model aids in distinguishing DOA from DOA plus and guides initial hOPA1 mutation treatment strategies.
引用
收藏
页数:25
相关论文
共 50 条
  • [41] Distributed abnormalities of brain white matter architecture in patients with dominant optic atrophy and OPA1 mutations
    Maria A. Rocca
    Stefania Bianchi-Marzoli
    Roberta Messina
    Maria Lucia Cascavilla
    Massimo Zeviani
    Costanza Lamperti
    Jacopo Milesi
    Arturo Carta
    Gabriella Cammarata
    Letizia Leocani
    Eleonora Lamantea
    Francesco Bandello
    Giancarlo Comi
    Andrea Falini
    Massimo Filippi
    Journal of Neurology, 2015, 262 : 1216 - 1227
  • [42] Dominant Optic Atrophy Caused by the c.1334G>A Mutation of the OPA1 Gene
    Choi, Yoon Seok
    Oh, Jun Ho
    Hwang, Su-Kyeong
    Chun, Bo Young
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2022, 63 (03): : 325 - 329
  • [43] OPA1 haploinsufficiency induces a BNIP3-dependent decrease in mitophagy in neurons: relevance to Dominant Optic Atrophy
    Moulis, Manon F.
    Millet, Aurelie M.
    Daloyau, Marlene
    Miquel, Marie-Christine
    Ronsin, Brice
    Wissinger, Bernd
    Arnaune-Pelloqin, Laetitia
    Belenguer, Pascale
    JOURNAL OF NEUROCHEMISTRY, 2017, 140 (03) : 485 - 494
  • [44] Electrophysiological and Histologic Assessment of Retinal Ganglion Cell Fate in a Mouse Model for OPA1-Associated Autosomal Dominant Optic Atrophy
    Heiduschka, Peter
    Schnichels, Sven
    Fuhrmann, Nico
    Hofmeister, Sabine
    Schraermeyer, Ulrich
    Wissinger, Bernd
    Alavi, Marcel V.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (03) : 1424 - 1431
  • [45] Molecular Impairment Mechanisms of Novel OPA1 Mutations Predicted by Molecular Modeling in Patients With Autosomal Dominant Optic Atrophy and Auditory Neuropathy Spectrum Disorder
    Namba, Kazunori
    Mutai, Hideki
    Takiguchi, Yoichiro
    Yagi, Hirotaka
    Okuyama, Takahide
    Oba, Shuntaro
    Yamagishi, Ryosuke
    Kaneko, Hiroki
    Shintani, Tomoko
    Kaga, Kimitaka
    Matsunaga, Tatsuo
    OTOLOGY & NEUROTOLOGY, 2016, 37 (04) : 394 - 402
  • [46] A Plasma Metabolomic Signature Involving Purine Metabolism in Human Optic Atrophy 1 (OPA1)-Related Disorders
    Bocca, Cinzia
    Nzoughet, Judith Kouassi
    Leruez, Stephanie
    Amati-Bonneau, Patrizia
    Ferre, Marc
    Kane, Mariame-Selma
    Veyrat-Durebex, Charlotte
    de la Barca, Jua Manuel Chao
    Chevrollier, Arnaud
    Homedan, Chadi
    Verny, Christophe
    Milea, Dan
    Procaccio, Vincent
    Simard, Gilles
    Bonneau, Dominique
    Lenaers, Guy
    Reynier, Pascal
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (01) : 185 - 195
  • [47] Processing of OPA1 with a novel N-terminal mutation in patients with autosomal dominant optic atrophy: Escape from nonsense-mediated decay
    Sciezynska, Aneta
    Ruszkowska, Ewelina
    Szulborski, Kamil
    Rydz, Katarzyna
    Wierzbowska, Joanna
    Kosinska, Joanna
    Rekas, Marek
    Ploski, Rafal
    Szaflik, Jacek Pawel
    Oldak, Monika
    PLOS ONE, 2017, 12 (08):
  • [48] Genomics combined with a protein informatics platform to assess a novel pathogenic variant c.1024 A>G (p.K342E) in OPA1 in a patient with autosomal dominant optic atrophy
    Ahuja, Abhimanyu S.
    Selvam, Pavalan
    Vadlamudi, Charitha
    Chopra, Hayley
    Richter, John E., Jr.
    Macklin, Sarah K.
    Samreen, Ayesha
    Helmi, Haytham
    Mohammaad, Ahmed N.
    Hines, Stephanie
    Davila, Maria C.
    Atwal, Paldeep S.
    Caulfield, Thomas R.
    OPHTHALMIC GENETICS, 2020, 41 (06) : 563 - 569
  • [49] OPA1 mutations in dominant optic atrophy: domain-specific defects in mitochondrial fusion and apoptotic regulation
    Kexuan Zhang
    Wenqing Zhang
    Lin Zhang
    Xiaorong Hou
    Runyi Tian
    Zhengmao Hu
    Lili Yin
    Zhonghua Hu
    Journal of Translational Medicine, 23 (1)
  • [50] OPA3-Related Autosomal Dominant Optic Atrophy and Cataract with Ataxia and Areflexia
    Ayrignac, X.
    Liauzun, C.
    Lenaers, G.
    Renard, D.
    Amati-Bonneau, P.
    de Seze, J.
    Dollfus, H.
    Hamel, C.
    Bonneau, D.
    Labauge, P.
    EUROPEAN NEUROLOGY, 2012, 68 (02) : 108 - 110